{
 "PrintNo":"S1774","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-01-15T13:48:32.26614Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-15","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1232,"Name":"James Skoufis","Short":"SKOUFIS"},{"ID":1224,"Name":"Anna Kaplan","Short":"KAPLAN"}],
 "Title":"Relates to adding W-18 to the schedule of controlled substances",
 "Summary":"Adds W-18(4-chloro-N-{1-{2-(4-nitrophenyl)ethyl} 2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding W-18 to the schedule of controlled substances",
 "SameAsPrintNo":"A486-2021","PreviousVersions":["S5112-2017","S5221-2019"]
}